NightFood’s TechForce Robotics signs joint development deal with Oncotelic Therapeutics

ONCOTELIC THERAPEUTICS INC

OTLC

0.00

NIGHTFOOD HLDGS INC

NGTF

0.00

Nightfood Holdings, operating as TechForce Robotics, entered a joint development, manufacturing, and licensing agreement with Oncotelic Therapeutics.
Collaboration targets development and commercialization of AI-enabled, GMP-compliant robotic systems for pharmaceutical manufacturing and laboratory automation.
Deal marks TechForce Robotics’ expansion into regulated biopharma automation markets.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NightFood Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604060830PRIMZONEFULLFEED9684451) on April 06, 2026, and is solely responsible for the information contained therein.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.